Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

A compound found in nearly every energy drink may also be feeding aggressive blood cancers. Researchers discovered that leukemia cells absorb taurine to grow faster — and extra taurine only made ...

A pioneering biobattery has been shown to reduce tumor growth in the body and could hold the key to a new drug-free ...

The lung cancer diagnostics market encompasses tools, techniques, and services for detecting lung cancer, including imaging, ...

We asked doctors and experts which foods have been shown to potentially decrease cancer risk. 1. Berries. Berries are rich in ...

Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early ...

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced that the Company will ...

Another risk of smoking cigarettes is periodontal disease, otherwise known as gum disease. This is because smoking causes ...

Bispecific anti-PD1/VEGF remains one of the hottest topics in the oncology field. Click here for a detailed analysis.